We are live on ! Find out more
AIP

ARS Investment Partners Portfolio holdings

AUM $2.29B
1-Year Est. Return 113.95%
This Fund
S&P 500
This Quarter Est. Return
+40.9%
1 Year Est. Return
+113.95%
3 Year Est. Return
+260.1%
5 Year Est. Return
+332.48%
10 Year Est. Return
+1,634.5%
AUM
$531M
AUM Growth
+$117M
Cap. Flow
-$11.1M
Cap. Flow %
-2.1%
Top 10 Hldgs %
55.34%
Holding
103
New
15
Increased
18
Reduced
31
Closed
30

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$23.9M
2
JNJ icon
Johnson & Johnson
JNJ
+$12M
3
ABBV icon
AbbVie
ABBV
+$6.57M
4
TTD icon
Trade Desk
TTD
+$5.47M
5
VICR icon
Vicor
VICR
+$4.27M

Sector Composition

Rank Sector Weight
1 Technology 37.16%
2 Healthcare 19.28%
3 Industrials 10.71%
4 Financials 9.9%
5 Communication Services 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOC icon
26
Northrop Grumman
NOC
$79.2B
$6.73M 1.27%
21,884
-300
-1% -$98.4K
AEP icon
27
American Electric Power
AEP
$68.8B
$6M 1.13%
75,353
-44,075
-37% -$3.6M
STX icon
28
Seagate
STX
$190B
$5.66M 1.06%
116,847
+12,643
+12% +$634K
MDLZ icon
29
Mondelez International
MDLZ
$79.9B
$5.63M 1.06%
110,022
-2,243
-2% -$115K
VICR icon
30
Vicor
VICR
$10.1B
$5.47M 1.03%
+75,993
New +$4.27M
PEP icon
31
PepsiCo
PEP
$189B
$5.32M 1%
40,190
-638
-2% -$84.1K
BX icon
32
Blackstone
BX
$109B
$5M 0.94%
88,285
+1,054
+1% +$55.5K
BLK icon
33
Blackrock
BLK
$176B
$4.99M 0.94%
9,166
+1,236
+16% +$624K
ASND icon
34
Ascendis Pharma A/S
ASND
$16B
$4.52M 0.85%
30,571
-177
-0.6% -$24.3K
GOOG icon
35
Alphabet (Google) Class C
GOOG
$4.4T
$4.44M 0.84%
62,820
-300
-0.5% -$20.2K
XEL icon
36
Xcel Energy
XEL
$48.2B
$3.75M 0.71%
60,082
BMY icon
37
Bristol-Myers Squibb
BMY
$130B
$3.56M 0.67%
60,621
+30,548
+102% +$1.83M
RPRX icon
38
Royalty Pharma
RPRX
$25.6B
$3.54M 0.67%
+72,956
New +$3.61M
ROK icon
39
Rockwell Automation
ROK
$50.1B
$2.38M 0.45%
+11,162
New +$2.16M
NET icon
40
Cloudflare
NET
$107B
$2.37M 0.45%
+65,915
New +$1.84M
CL icon
41
Colgate-Palmolive
CL
$74.4B
$1.92M 0.36%
26,251
-600
-2% -$42.6K
CNI icon
42
Canadian National Railway
CNI
$77.1B
$1.54M 0.29%
17,447
AMAT icon
43
Applied Materials
AMAT
$424B
$1.45M 0.27%
23,970
-9,000
-27% -$486K
TMO icon
44
Thermo Fisher Scientific
TMO
$214B
$1.17M 0.22%
3,222
NEM icon
45
Newmont
NEM
$110B
$1.14M 0.21%
+18,475
New +$1.09M
UNP icon
46
Union Pacific
UNP
$176B
$1.06M 0.2%
6,285
ASML icon
47
ASML
ASML
$645B
$1.03M 0.19%
2,803
-100
-3% -$31.4K
META icon
48
Meta Platforms (Facebook)
META
$1.5T
$887K 0.17%
3,908
+52
+1% +$10.9K
ERIC icon
49
Ericsson
ERIC
$33B
$873K 0.16%
93,836
CLF icon
50
Cleveland-Cliffs
CLF
$7.22B
$745K 0.14%
135,000
+4,900
+4% +$23.8K

Similar funds

ARS Investment Partners's Q2 2020 Portfolio in Review

As of Q2 2020, ARS Investment Partners held 103 positions worth $531M, up 28% from $414M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

ARS Investment Partners's Q2 2020 filing shows 15 new, 18 increased, 31 reduced and 30 closed positions. Its largest new stake was RTX Corp: 382,880 shares worth $23.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $13.7M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Healthcare and Industrials.

  • ARS Investment Partners's largest Q2 2020 buy was RTX Corp: 382,880 shares worth $23.6M.
  • ARS Investment Partners added most to AbbVie in Q2 2020, an estimated $6.57M increase.
  • ARS Investment Partners's biggest Q2 2020 reduction was Zscaler, cutting an estimated $8.8M.
  • ARS Investment Partners fully exited State Street SPDR S&P 500 ETF Trust in Q2 2020, selling an estimated $13.7M.
  • ARS Investment Partners's ten largest holdings make up 55% of its $531M portfolio in Q2 2020.
  • ARS Investment Partners opened 15 new positions and closed 30 in Q2 2020.
  • ARS Investment Partners's portfolio value rose 28% quarter-over-quarter to $531M.

Based on ARS Investment Partners's 13F filing for Q2 2020, filed 13 Aug 2020.